ESR1 and breast carcinoma: Recently, various strategies for treating breast cancer have emerged, including antiestrogenic therapy with estrogen receptor modulators such as raloxifene hydrochloride (RLX) (Figure 1A), which is specifically used for (ER+) breast cancer.